Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yan-Li Ding

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
European Journal of Pharmacology|February 13, 2022
ATRA promotes PD-L1 expression to control gastric cancer immune surveillanceZhi-Lu Ma, Yan-Li Ding, Jing Jing, et al.
Acta Biochimica Et Biophysica Sinica|June 10, 2005
Generation and characterization of C305, a murine neutralizing scFv antibody that can inhibit BLyS binding to its receptor BCMAMei-Yun Liu, Wei Han, Yan-Li Ding, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
European Journal of Pharmacology|February 13, 2022
ATRA promotes PD-L1 expression to control gastric cancer immune surveillanceZhi-Lu Ma, Yan-Li Ding, Jing Jing, et al.
Acta Biochimica Et Biophysica Sinica|June 10, 2005
Generation and characterization of C305, a murine neutralizing scFv antibody that can inhibit BLyS binding to its receptor BCMAMei-Yun Liu, Wei Han, Yan-Li Ding, et al.
Pageof 2